Selected research
Industry Research
Pharmaceutical Safety Testing Industry Research Report 2026
Market perspective
The global Pharmaceutical Safety Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pharmaceutical Safety Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pharmaceutical Safety Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pharmaceutical Safety Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pharmaceutical Safety Testing include Eurofins, LabCorp, Fujifilm Wako, Charles River, SGS, Intertek Group, CTI, Frontage and Medicilon, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pharmaceutical Safety Testing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharmaceutical Safety Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmaceutical Safety Testing Market by Company
Eurofins
LabCorp
Fujifilm Wako
Charles River
SGS
Intertek Group
CTI
Frontage
Medicilon
Wuxi Biologics
Pharmaron
Pharmaceutical Safety Testing Segment by Type
Biological Drugs
Chemical Drugs
Pharmaceutical Safety Testing Segment by Application
Clinical
Non-clinical
Pharmaceutical Safety Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Safety Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Safety Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Safety Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharmaceutical Safety Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Biological Drugs
- Chemical Drugs
Applications
- Clinical
- Non-clinical
Companies covered
- Eurofins
- LabCorp
- Fujifilm Wako
- Charles River
- SGS
- Intertek Group
- CTI
- Frontage
- Medicilon
- Wuxi Biologics
- Pharmaron
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharmaceutical Safety Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Biological Drugs
- 2.2.3 Chemical Drugs
- 2.3 Pharmaceutical Safety Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Clinical
- 2.3.3 Non-clinical
- 2.4 Assumptions and Limitations
3 Pharmaceutical Safety Testing Breakdown Data by Type
- 3.1 Global Pharmaceutical Safety Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Pharmaceutical Safety Testing Forecasted Market Size by Type (2027-2032)
4 Pharmaceutical Safety Testing Breakdown Data by Application
- 4.1 Global Pharmaceutical Safety Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Pharmaceutical Safety Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pharmaceutical Safety Testing Market Perspective (2021-2032)
- 5.2 Global Pharmaceutical Safety Testing Growth Trends by Region
- 5.2.1 Global Pharmaceutical Safety Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pharmaceutical Safety Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Pharmaceutical Safety Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Pharmaceutical Safety Testing Market Dynamics
- 5.3.1 Pharmaceutical Safety Testing Industry Trends
- 5.3.2 Pharmaceutical Safety Testing Market Drivers
- 5.3.3 Pharmaceutical Safety Testing Market Challenges
- 5.3.4 Pharmaceutical Safety Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pharmaceutical Safety Testing Players by Revenue
- 6.1.1 Global Top Pharmaceutical Safety Testing Players by Revenue (2021-2026)
- 6.1.2 Global Pharmaceutical Safety Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Pharmaceutical Safety Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pharmaceutical Safety Testing Head Office and Area Served
- 6.4 Global Pharmaceutical Safety Testing Players, Product Type & Application
- 6.5 Global Pharmaceutical Safety Testing Manufacturers Established Date
- 6.6 Global Pharmaceutical Safety Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pharmaceutical Safety Testing Market Size (2021-2032)
- 7.2 North America Pharmaceutical Safety Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pharmaceutical Safety Testing Market Size by Country (2021-2026)
- 7.4 North America Pharmaceutical Safety Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pharmaceutical Safety Testing Market Size (2021-2032)
- 8.2 Europe Pharmaceutical Safety Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pharmaceutical Safety Testing Market Size by Country (2021-2026)
- 8.4 Europe Pharmaceutical Safety Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmaceutical Safety Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Pharmaceutical Safety Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pharmaceutical Safety Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pharmaceutical Safety Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pharmaceutical Safety Testing Market Size (2021-2032)
- 10.2 South America Pharmaceutical Safety Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pharmaceutical Safety Testing Market Size by Country (2021-2026)
- 10.4 South America Pharmaceutical Safety Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmaceutical Safety Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Pharmaceutical Safety Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pharmaceutical Safety Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pharmaceutical Safety Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Eurofins
- 12.1.1 Eurofins Company Information
- 12.1.2 Eurofins Business Overview
- 12.1.3 Eurofins Revenue in Pharmaceutical Safety Testing Business (2021-2026)
- 12.1.4 Eurofins Pharmaceutical Safety Testing Product Portfolio
- 12.1.5 Eurofins Recent Developments
- 12.2 LabCorp
- 12.2.1 LabCorp Company Information
- 12.2.2 LabCorp Business Overview
- 12.2.3 LabCorp Revenue in Pharmaceutical Safety Testing Business (2021-2026)
- 12.2.4 LabCorp Pharmaceutical Safety Testing Product Portfolio
- 12.2.5 LabCorp Recent Developments
- 12.3 Fujifilm Wako
- 12.3.1 Fujifilm Wako Company Information
- 12.3.2 Fujifilm Wako Business Overview
- 12.3.3 Fujifilm Wako Revenue in Pharmaceutical Safety Testing Business (2021-2026)
- 12.3.4 Fujifilm Wako Pharmaceutical Safety Testing Product Portfolio
- 12.3.5 Fujifilm Wako Recent Developments
- 12.4 Charles River
- 12.4.1 Charles River Company Information
- 12.4.2 Charles River Business Overview
- 12.4.3 Charles River Revenue in Pharmaceutical Safety Testing Business (2021-2026)
- 12.4.4 Charles River Pharmaceutical Safety Testing Product Portfolio
- 12.4.5 Charles River Recent Developments
- 12.5 SGS
- 12.5.1 SGS Company Information
- 12.5.2 SGS Business Overview
- 12.5.3 SGS Revenue in Pharmaceutical Safety Testing Business (2021-2026)
- 12.5.4 SGS Pharmaceutical Safety Testing Product Portfolio
- 12.5.5 SGS Recent Developments
- 12.6 Intertek Group
- 12.6.1 Intertek Group Company Information
- 12.6.2 Intertek Group Business Overview
- 12.6.3 Intertek Group Revenue in Pharmaceutical Safety Testing Business (2021-2026)
- 12.6.4 Intertek Group Pharmaceutical Safety Testing Product Portfolio
- 12.6.5 Intertek Group Recent Developments
- 12.7 CTI
- 12.7.1 CTI Company Information
- 12.7.2 CTI Business Overview
- 12.7.3 CTI Revenue in Pharmaceutical Safety Testing Business (2021-2026)
- 12.7.4 CTI Pharmaceutical Safety Testing Product Portfolio
- 12.7.5 CTI Recent Developments
- 12.8 Frontage
- 12.8.1 Frontage Company Information
- 12.8.2 Frontage Business Overview
- 12.8.3 Frontage Revenue in Pharmaceutical Safety Testing Business (2021-2026)
- 12.8.4 Frontage Pharmaceutical Safety Testing Product Portfolio
- 12.8.5 Frontage Recent Developments
- 12.9 Medicilon
- 12.9.1 Medicilon Company Information
- 12.9.2 Medicilon Business Overview
- 12.9.3 Medicilon Revenue in Pharmaceutical Safety Testing Business (2021-2026)
- 12.9.4 Medicilon Pharmaceutical Safety Testing Product Portfolio
- 12.9.5 Medicilon Recent Developments
- 12.10 Wuxi Biologics
- 12.10.1 Wuxi Biologics Company Information
- 12.10.2 Wuxi Biologics Business Overview
- 12.10.3 Wuxi Biologics Revenue in Pharmaceutical Safety Testing Business (2021-2026)
- 12.10.4 Wuxi Biologics Pharmaceutical Safety Testing Product Portfolio
- 12.10.5 Wuxi Biologics Recent Developments
- 12.11 Pharmaron
- 12.11.1 Pharmaron Company Information
- 12.11.2 Pharmaron Business Overview
- 12.11.3 Pharmaron Revenue in Pharmaceutical Safety Testing Business (2021-2026)
- 12.11.4 Pharmaron Pharmaceutical Safety Testing Product Portfolio
- 12.11.5 Pharmaron Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst